Literature DB >> 15145114

Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery.

Ryan Hutfless1, Radmila Kazanegra, Michael Madani, Meenakshi Awasthi Bhalla, Alisi Tulua-Tata, Amelia Chen, Paul Clopton, Cherimarie James, Albert Chiu, Alan S Maisel.   

Abstract

OBJECTIVES: The purpose of the present study was to assess whether preoperative and postoperative B-type natriuretic peptide (BNP) levels could be used as predictors of postoperative complications and outcomes in patients after open-heart surgery.
BACKGROUND: A variety of multifactor indexes have been proposed for preoperative risk assessment of patients undergoing cardiac surgery, but they have shown limited ability and utility in accurately predicting postoperative complications, hospital stay, and mortality.
METHODS: Subjects consisted of 98 male patients (63 +/- 9.1 years) undergoing open-heart surgery at the San Diego Veterans Administration Health System during a 19-month period. B-type natriuretic peptide levels were analyzed, and postoperative data recorded.
RESULTS: There was a higher preoperative BNP level in patients requiring the use of intra-aortic balloon pumps (IABPs) (mean BNP = 387 +/- 112 pg/ml vs. 181 +/- 25 pg/ml), in patients who died within one year (357 +/- 93 pg/ml vs. 184 +/- 26 pg/ml), and in patients with postoperative hospital stays of 10 days or more (307 +/- 68 pg/ml vs. 179 +/- 27 pg/ml). Receiver operating characteristic curves demonstrated preoperative BNP levels as predictors of postoperative IABP use, hospital stay <or=10 days, and mortality <1 year with areas under the curve of 0.70, 0.64, and 0.70, respectively. A BNP cut-off value above 385 pg/ml demonstrated high specificity (=90% in each) and accuracy (=86%, 79%, 85%, respectively) for predicting each of these end points.
CONCLUSIONS: Preoperative BNP levels >385 pg/ml predict the postoperative complications and one-year mortality after heart surgery. Postoperatively, elevated peak BNP levels and elevated change to peak BNP levels were associated with prolonged hospital stay and mortality within one year.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15145114     DOI: 10.1016/j.jacc.2003.12.048

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  31 in total

1.  Utility of N-terminal brain natriuretic peptide plasma concentrations in comparison to lactate and troponin in children with congenital heart disease following open-heart surgery.

Authors:  T S Mir; C Haun; C Lilje; S Läer; J Weil
Journal:  Pediatr Cardiol       Date:  2006 Mar-Apr       Impact factor: 1.655

2.  Prognostic value of B-type natriuretic peptide in surgical palliation of children with single-ventricle congenital heart disease.

Authors:  J G Berry; B Askovich; R E Shaddy; J A Hawkins; C G Cowley
Journal:  Pediatr Cardiol       Date:  2007-08-04       Impact factor: 1.655

3.  The relationship between BNP, NTproBNP and echocardiographic measurements of systemic blood flow in very preterm infants.

Authors:  K König; K J Guy; G Walsh; S M Drew; A Watkins; C P Barfield
Journal:  J Perinatol       Date:  2014-02-06       Impact factor: 2.521

4.  Comparison of the utility of preoperative versus postoperative B-type natriuretic peptide for predicting hospital length of stay and mortality after primary coronary artery bypass grafting.

Authors:  Amanda A Fox; Jochen D Muehlschlegel; Simon C Body; Stanton K Shernan; Kuang-Yu Liu; Tjorvi E Perry; Sary F Aranki; E Francis Cook; Edward R Marcantonio; Charles D Collard
Journal:  Anesthesiology       Date:  2010-04       Impact factor: 7.892

Review 5.  Natriuretic peptides in the management of aortic stenosis.

Authors:  Jutta Bergler-Klein
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

6.  Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials.

Authors:  Arthur M Feldman; Douglas L Mann; Lilin She; Michael R Bristow; Alan S Maisel; Dennis M McNamara; Ryan Walsh; Dorellyn L Lee; Stanislaw Wos; Irene Lang; Gretchen Wells; Mark H Drazner; John F Schmedtje; Daniel F Pauly; Carla A Sueta; Michael Di Maio; Irving L Kron; Eric J Velazquez; Kerry L Lee
Journal:  Circ Heart Fail       Date:  2013-04-12       Impact factor: 8.790

7.  Value of brain natriuretic peptide in the perioperative follow-up of children with valvular disease.

Authors:  Pierre Tissières; Eduardo da Cruz; Walid Habre; Yacine Aggoun; Noury Mensi; Afksendyios Kalangos; Maurice Beghetti
Journal:  Intensive Care Med       Date:  2008-02-19       Impact factor: 17.440

Review 8.  Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery.

Authors:  Alexandre Mebazaa; Antonis A Pitsis; Alain Rudiger; Wolfgang Toller; Dan Longrois; Sven-Erik Ricksten; Ilona Bobek; Stefan De Hert; Georg Wieselthaler; Uwe Schirmer; Ludwig K von Segesser; Michael Sander; Don Poldermans; Marco Ranucci; Peter C J Karpati; Patrick Wouters; Manfred Seeberger; Edith R Schmid; Walter Weder; Ferenc Follath
Journal:  Crit Care       Date:  2010-04-28       Impact factor: 9.097

9.  Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass grafting.

Authors:  Amanda A Fox; Stanton K Shernan; Charles D Collard; Kuang-Yu Liu; Sary F Aranki; Stacia M DeSantis; Petr Jarolim; Simon C Body
Journal:  J Thorac Cardiovasc Surg       Date:  2008-08       Impact factor: 5.209

10.  Relationship between B-type natriuretic peptide levels and echocardiographic indices of left ventricular filling pressures in post-cardiac surgery patients.

Authors:  Alessandro Salustri; Elena Cerquetani; Mara Piccoli; Guglielmo Pastena; Alfredo Posteraro; Elisabetta Amici; Salvatore La Carrubba; Sherif Bakir; Wael Abdulrahman Al Mahmeed
Journal:  Cardiovasc Ultrasound       Date:  2009-10-28       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.